P A Janssen
About
In The Last Decade
P A Janssen
28 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Molecular Biology 694
- Cellular and Molecular Neuroscience 688
- Physiology 308
- Cardiology and Cardiovascular Medicine 200
- Pharmacology 130
Countries citing papers authored by P A Janssen
This map shows the geographic impact of P A Janssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P A Janssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P A Janssen more than expected).
Fields of papers citing papers by P A Janssen
This network shows the impact of papers produced by P A Janssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P A Janssen. The network helps show where P A Janssen may publish in the future.
Co-authorship network of co-authors of P A Janssen
This figure shows the co-authorship network connecting the top 25 collaborators of P A Janssen. A scholar is included among the top collaborators of P A Janssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P A Janssen. P A Janssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 90 | |
| 3 | 10 | |
| 4 | 5-Hydroxytryptamine and thromboxane A2 in ischaemic heart disease. | 15 |
| 5 | 71 | |
| 6 | 12 | |
| 7 | 49 | |
| 8 | 55 | |
| 9 | 16 | |
| 10 | 175 | |
| 11 | 39 | |
| 12 | Pharmacology of the specific histamine H1-antagonist astemizole. | 40 |
| 13 | Serotonergic responses in vascular and non-vascular tissues. | 25 |
| 14 | 146 | |
| 15 | Vascular activity of ketanserin (R 41 468), a selective 5-HT2 receptor antagonist. | 6 |
| 16 | 5 | |
| 17 | Arterial blood pressure and heart rate changes during self-stimulation by dogs in the basal forebrain region, lateral preoptic area, hypothalamus, ventral midbrain and amygdala. | 9 |
| 18 | Preliminary data on antiserotonin effects of oxatomide, a novel anti-allergic compound. | 12 |
| 19 | 12 | |
| 20 | Suprofen, a potent antagonist of sodium urate crystal-induced arthritis in dogs. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.